Dermatology

A new study reported no increased incidence of heart disease in patients treated for chronic urticaria, despite prior research highlighting a potential association with other cardiac risk precursors.

An over-the-counter (OTC) treatment was considered superior to both the corticosteroid and an emollient cream in improving skin hydration.

Researchers highlight a new set of tests that could streamline the process involved in identifying autoimmune chronic urticaria.

Previous research showed probiotics given to pregnant women during certain stages of pregnancy and post delivery reduced the likelihood of atopic dermatitis in their children. Recently published reports; however, may not agree.

Patients who have either chronic idiopathic urticaria (CIU) or chronic spontaneous urticaria (CSU) who take oral corticosteroids (OCS) face a greater risk of side effects as well as higher total healthcare costs, according to a recent study.

“While the concept of biofilms in atopic dermatitis is relatively new, antimicrobial and biofilm dispersing agents have been included in the treatment regimen for atopic dermatitis for decades," according to the study authors.

Multiple measurements of skin integrity and function were applied to distinguish between the effects of topical emollient products in a recent study. Two popular products in the UK were determined to transiently improve the skin barrier that is thought to be defective in atopic dermatitis (AD), and another product was confirmed to be damaging.

Researchers report that atopic dermatitis (AD) is associated with increased risk of ADHD in adults and children. Patients with more severe AD were at even higher risk.

A modified Goeckerman regimen was associated with significant improvement of symptoms in patients with chronic, severe atopic dermatitis.

When a patient is diagnosed with chronic idiopathic urticaria, there are several things doctors can do to help them. The process to get the proper diagnosis can take several weeks, which can complicate the situation for patients.

People can experience bouts of urticaria over the course of their lives, but usually they only last for a matter of days. When the symptoms last six weeks or more, it can be classified as chronic idiopathic urticaria.

It appears that 300 mg of omalizumab (Xolair/Genentech) is effective in reducing angioedema, according to the results of a new study.

The stem cells can be turned into brain cells in laboratories, which can give scientists a better understanding of the genes and characteristics of brain cells that bipolar disorder patients have.

Severe atopic dermatitis (AD) symptoms of shorter duration were more likely to improve in allergen sensitized patients receiving desensitizing immunotherapy, than severe symptoms of longer duration or more moderate symptoms, according to a new observational cohort study.

Childhood atopic dermatitis (AD) usually resolves before adulthood, a meta-analysis of cases showed. Those patients who did see their AD persist were more likely to be female, to have been older at onset, and to have relatively severe AD.

Across the board, researchers saw that studies of active smokers showed increased prevalence of the skin condition, regardless of age or region. It isn't quite clear, though, whether smoking causes AD or AD causes people to smoke.

Topical corticosteroid worked as well as bleach in transforming the microbiota of affected skin to that of healthy skin, an NYU study found.

In the past 15 years, no new topical AD treatments have been approved. Crisaborole, however, could be an efficient, safe, non-steoidal treatment option, according to the results of two recent phase III studies.

For millions of Americans, including as many as one in four children, the painful skin irritation of atopic dermatitis (AD, or eczema), may only be the tip of the iceberg.

Researchers have reported that higher serum clusterin levels in children may be linked with atopic dermatitis symptom, potentially providing a candidate molecule to reflect disease’s severity.

Researchers have reported that higher serum clusterin levels in children may be linked with atopic dermatitis symptom severity.